Wound-Healing Markers Revealed by Proximity Extension Assay in Tears of Patients following Glaucoma Surgery by Csősz, Éva et al.
 International Journal of 
Molecular Sciences
Article
Wound-Healing Markers Revealed by Proximity
Extension Assay in Tears of Patients following
Glaucoma Surgery
Éva Cso˝sz 1,2,* , Noémi Tóth 3, Eszter Deák 1,3, Adrienne Csutak 3,† and József To˝zsér 1,2,†
1 Biomarker Research Group, Department of Biochemistry and Molecular Biology, Faculty of Medicine,
University of Debrecen, Egyetem ter 1., 4032 Debrecen, Hungary; deak.eszter@med.unideb.hu (E.D.);
tozser@med.unideb.hu (J.T.)
2 Proteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine,
University of Debrecen, Egyetem ter 1., 4032 Debrecen, Hungary
3 Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98.,
4032 Debrecen, Hungary; tothnoemi111@gmail.com (N.T.); acsutak@med.unideb.hu (A.C.)
* Correspondence: cseva@med.unideb.hu; Tel.: +36-52-416-432
† These authors contributed equally to this work.
Received: 15 October 2018; Accepted: 11 December 2018; Published: 18 December 2018


Abstract: Tears are a constantly available and highly valuable body fluid collectable by non-invasive
techniques. Although it can give information on ocular status and be used for follow-ups, tear
analysis is challenging due to the low amount of sample that is available. Proximity extension
assay (PEA) allows for a sensitive and scalable analysis of multiple proteins in a single run from
a one-µL sample, so we applied this technique and examined the amount of 184 proteins in tears
collected at different time points after trabeculectomy. The success rate of this surgical intervention
highly depends on proper wound healing; therefore, information on the process is indispensable.
We observed significantly higher levels of IL-6 and MMP1 at the early time points (day one, two,
and four) following trabeculectomy, and the protein amounts went back to the level observed before
the surgery three months after the intervention. Patients with or without complications were tested,
and proteins that have roles in the immune response and wound healing could be observed with
altered frequency and amounts in the cases of patients with complications. Our results highlight
the importance of inflammation in wound-healing complications, and at the same time, indicate the
utility of PEA in tear analysis.
Keywords: proximity extension assay; tear; glaucoma; wound healing; inflammation
1. Introduction
Glaucoma is a multifactorial neurodegenerative eye disease that affects millions of people and is
a leading cause of blindness worldwide [1]. In glaucoma, the neuropathy of the optic nerve and the
progressive and irreversible loss of retinal ganglion cells can be observed, resulting in the atrophy of
the optic nerve and the loss of visual functions, leading to blindness [2,3]. The most important form of
treatment is the reduction of the increased intraocular pressure (IOP), which can delay the glaucoma
progression and prevent visual field loss. Most of the patients are initially treated and well controlled
with topical medication (eye drops), but surgery becomes necessary when the desired IOP cannot be
reached. Some minimal invasive microsurgery procedures are available, but the most widely used gold
standard surgical intervention in open angle glaucoma is still filtration surgery. The latter involves
trabeculectomy, which is an invasive procedure associated with a relatively high complication and
failure rate [4,5]. During trabeculectomy, a part of the trabecular meshwork is removed, and a channel
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is created between the anterior chamber and the subconjunctival space, leading to controlled leaking
of the aqueous humor, and thus the lowering of the IOP. One of the key features of the success of
trabeculectomy is the wound healing, which might be impaired, making the postoperative IOP control
impossible [4].
Wound healing is a well-organized cascade of closely linked processes starting with a coagulative
and inflammatory phase, followed by the proliferative and repair phase, and ending with the
remodeling phase [6]. Ocular wound healing differs from that observed in case of skin [7]; right
after the injury in the first few hours in the epithelial cell layer, the phases of latency, migration,
and proliferation occur with the proliferation phase peaking around 24 hours after the injury [8,9].
The ATP released from the injured cells and the damage-associated molecular patterns made available
by the injury increase the apoptosis and toll-like receptor signaling, which leads to the production
of pro-inflammatory cytokines such as interleukins IL-1α and β, IL-6, and tumor necrosis factor α
(TNFα) [10,11]. The release of matrix metalloproteinases (MMPs) triggers the extracellular matrix
rearrangements, making possible fibronectin polymerization, the remodeling of cellular junctions, the
formation of focal contacts at wound margins, and the migration of cells to cover the wound [8,12].
These steps are followed by cell proliferation, the formation of a basement membrane, and the
restoration of barrier functions orchestrated by keratinocyte growth factor (KGF), hepatocyte growth
factor (HGF), epidermal growth factor (EGF), platelet-derived growth factors (PDGF), neural growth
factor (NGF), transforming growth factors (TGF), and cytokines (mainly IL-1, IL-6, and IL-8, as
reviewed by [8,11,13]). At the same time, keratocyte apoptosis in the stroma is followed by the
recruitment of immune cells and keratocyte transformation to fibroblasts and myofibroblasts [14–16].
The transformed and the newly formed cells migrate to the site of injury to fill up and close the
wound. Less information is available regarding the endothelial cells in which the migration of the
endothelial cells to fill up the gap, and the secretion of basement membrane was observed to happen
in an approximately six hours to time interval of several days [8,12].
The phases of ocular wound healing are regulated by the tightly controlled appearance of
cytokines and chemokines released during injury. These molecules in turn lead to the appearance
of other cytokines and growth factors, making possible the coordination of molecular events that is
characteristic to the latency, migration, and proliferation phases both in the epithelial and stromal
layers. Epithelial cells express interleukins (IL), tumor necrosis factor (TNF) α, and growth factors
under normal conditions, and they are activated/released during the injury [11]. Growth factors and
cytokines from tears that are released upon the injury, which in turn increase the production of other
cytokines and growth factors [9,17]. EGF and PDGF are released during the injury, and the amounts
of KGF and HGF also are increased [13,17]. Meanwhile, the controlled activation of MMPs makes
the large extracellular matrix rearrangements that are required for cell migration and wound closure
possible. The wound-healing process ends with a slow and long remodeling phase that lasts for up to
a year and ends up, under normal conditions, with the scarless healing that is necessary for proper
vision [8,12,18].
Each step of the process can be affected, leading to complications and ineffective surgical
intervention. Reepithelization typically occurs mainly three to five days after surgery [12], but
complications appear later (weeks or months) after surgery [19,20], highlighting the importance
of the early events of wound healing.
In order to get more information on the ocular wound-healing process following trabeculectomy,
we decided to use tears, the accessible body fluid that can be collected in tiny amounts by non-invasive
techniques. To examine multiple proteins in the same sample, methods permitting multiplexing are
required. Such methods can be based on mass spectrometry, immunological detection, or a combination
of different methods. Immunological detection in most of the settings is more sensitive compared to
mass spectrometry, but the dynamic range of the mass spectrometry usually overcomes that which is
achievable by the immunological methods [21], and moreover, it is the only unbiased method. At the
same time, it is difficult to work reliably in many cases with many different biological materials by
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mass spectrometry. A novel approach with exceptional specificity and scalability is the combination of
antibody-based detection with the well-defined methods that are used during quantitative polymerase
chain reaction (qPCR). The proximity extension assay (PEA) uses two polyclonal antibodies raised
against the protein of interest and linked to complementary oligonucleotides. When the two antibodies
bind the protein of interest, oligonucleotides hybridize. After hybridization, DNA polymerase is added,
and qPCR is carried out, permitting the quantification of the protein-specific oligonucleotide sequences.
The results are given as normalized expression units (NPX) and can provide the relative quantification
of proteins [22]. This method, by combining two, individually powerful analysis techniques, makes
relative quantification of multiple proteins possible in very low sample amounts, providing an effective
tool for the analysis of body fluids available in low volumes [23–26].
During this work, our aim was to apply the PEA method on tear analysis to get more information
on the amounts of proteins that have roles in the different phases of the ocular wound-healing process,
with highlights on complications following trabeculectomy.
2. Results and Discussion
The tightly regulated process of ocular wound healing makes the scarless healing of tissue injuries
possible, and involves a multitude of molecules playing role in the regulation of the biochemical events
of the wound-healing steps. In order to examine the relative amount of multiple tear molecules, giving
information on a novel method for ocular wound healing, PEA was applied for the analysis of tear
proteins. This method permits the analysis of up to 92 proteins per panel using only one µL of body
fluid, which can be extremely beneficial in the case of body fluids that are collectable in low volume
such as tears, where the typical amount collected is 5–10 µL [27].
2.1. Tear Sample Analysis by PEA
Tear samples were analyzed by PEA at Olink Proteomics (Uppsala, Sweden) using the
cardiovascular (CVD) II and the inflammation panels. Each panel included 92 proteins and four
internal controls, providing information about 184 proteins altogether (Table S1). Due to technical
issues identified with the brain-derived neurotrophic factor (BDNF) assay, the BDNF protein could
not be analyzed. According to our data, 11 out of the analyzed 184 proteins do not appear in tears.
These proteins are fibroblast growth factor 5, interferon gamma, interleukins IL2, IL20, and IL24,
interleukin receptors IL2RB, IL15RA, and IL22RA1, signaling lymphocytic activation molecule (SLAM)
family member 1, thymic stromal lymphopoietin (TSLP), and tumor necrosis factor. Internal controls
were added to each sample to monitor the quality of assay performance and the quality of individual
samples. Quality control (QC) was performed in two steps: i) each sample plate was evaluated based
on the standard deviation (SD) of the internal controls, and only data from the sample plate that pass
quality control (SD < 0.2 NPX) were reported, and ii) the quality of each sample was assessed by
evaluating the deviation from the median value of the controls for each individual sample. Samples
that deviate less than 0.3 NPX from the median pass the quality control. In the CVD II and inflammation
panels, 55 out of 60 and 57 out of 60 samples passed the QC, respectively (Table S2). Most proteins
of the could be measured with <5% coefficient of variation (CV) with a typical intraassay CV of 4%
(Figure 1).
In the case of the CVD II panel, 60% of the proteins (55 out of 92) could be detected in more than
75% of the samples, while in case of the inflammation panel, this value was 45% (41 proteins out of 92)
(Table S2). Compared to the more than 90% detectability for proteins included in the CVD II panel
and >75% for proteins included in the inflammation panel observed in plasma, the values obtained
for tear analysis are lower, but it should be mentioned that the protein composition of tears was
substantially different from that of plasma [28]. At the same time, NPX values may differ depending
on the sample preparation methods, sample matrices, or the pathological conditions that are present.
However, based on our data, both the CVD II and inflammation panels that are used primarily for
plasma protein analysis work well in case of tears, and they provide easy-to-use tools for the multiplex
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analysis of proteins from small amounts of samples. This is of extremely high importance, because
the amount of basal tear that is available is usually low, in some cases hindering the administration of
replicates in very sensitive mass spectrometry analyses. Reflex tear can be collected in higher amounts,
but its quality is significantly different compared to basal tear [29]. Considering the qualitative and
quantitative differences between the basal and reflex tear, arguments against pooling for tear analysis,
and that the method does not require technical replicates due to the application of proper controls,
PEA can be considered a method of choice for the analysis of individual, basal tear samples.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  4 of 20 
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2.2. Examination of Protein-Level Changes after Trabeculectomy
To interrogate t e role that sel cted tear protei s have in wound healing, the amount of
184 proteins was analyzed in a follow-up study in tea samples originat g from patients who
underwent trabeculectomy. T e starting p i t of the study was day zero, when the samples w re
collected bef re the surgical intervention. By examining cha ges in the level of interleukin , growth
factors, extracellular m trix components, nd oth r proteins with poss ble roles in wou d aling in
early and later time points (postoperative day one, day two, day four, and th e months), ur aim w to
u derstand the subtl events related to the different pha es of wound healing. After eviewing pati nt
record , e could not find bleb leak, hypotony, hyphema, choroidal effusion, choroidal hemorrhage,
blebitis, or endophthalmitis. In the case of three patients, the surgical intervention could not lower the
high IOP properly, and the administration of IOP-loweri g ye drops was required as indi t d
Table S3. This latter group was designated as the “group with complicat ons”.
The mount and the frequency f the 184 tested proteins were examined in the groups with and
without complications using a step-by-step procedure. First, a qualitative analysis was carried out,
followed by quantitativ analysis, h at map analysis, ierarchical clustering, and statistical an lysis.
The prot ins with altered frequency or the amount between the groups with and without complications
were subjected to functional analysis. First, the network of proteins was created with the help of
String (https://string-db.org/) and analyzed, follow d by Gene Ontology (GO) enrichment analysis.
The String database provides an easy-to-use tool for analyzing protein–protein interaction networks,
and gives information on the structure and function of proteins as retrieved from curated databases
such as UniProt, PDB, Ensembl, etc. The analysis of the enriched GO functions can also be done; the
enriched functions, the false discovery rate, and the number of proteins participating in the specified
functions can be listed [30,31].
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Proteins where there was at least a 20% difference in their frequency between the groups with
or without complication (Table 1, Table S4) were introduced into String network analysis (Figure 2).
The network of proteins that appear less likely in the samples of patients belonging to group with
complications contains 17 proteins. The A disintegrin and metallopeptidase with thrombospondin type
1 motif 13 (ADAMTS13), alpha-1-microglobulin/bikunin precursor (AMBP), chemokine (C-C motif)
ligand 3 (CCL3), CD40 ligand, CD84 molecule, carbonic anhydrase (CA5A), 2,4-dienoyl CoA reductase
1 (DECR1), IgG Fc fragment low affinity receptor (FCGR2B), fibroblast growth factor 23 (FGF23),
gastric intrinsic factor (GIF), leptin (LEP), macrophage receptor with collagenous structure (MARCO),
atrial natriuretic factor (BNP/NPPB), renin (REN), thrombopoietin (THPO), tumor necrosis factor
superfamily member 14 (TNFSF14), and uridine diphosphate-glucose glycoprotein glucosyltransferase
1 (UGGT1) appear less likely in the samples originating from patients with complications. The enriched
GO functions are related to receptor binding, the regulation of MAPK cascade, and immune regulation
(Figure 2a). CD84 has a role in modulating the activation and differentiation of immune cells, the
mitochondrial DECR1 and CA5A participate in metabolism, and the gastric intrinsic factor has a role in
cyanocobalamin absorption. According to functional analysis, UGGT1 has a role in the quality control
of protein folding. It recognizes glycoproteins with minor folding defects, reglucosylates them, and
facilitates their recycling to the endoplasmic reticulum [32]. Eleven of these proteins were already found
to be related to wound healing (Table 1). It was shown that leptin and NPPB promote wound healing
in the skin [33–35], and FGFs facilitate cell migration and regeneration during wound healing [36].
In case of renin, data are not clear; the renin-angiotensin system is implicated in wound healing but,
depending on the conditions, it drives the system either to pro-inflammatory, pro-proliferative, and
pro-fibrotic, or anti-inflammatory, anti-proliferative, and anti-fibrotic directions [37]. In the case of
the CD40 ligand, TNFSF14, CCL3, and ADAMTS13, it was shown that their lack or decreased level
leads to impaired wound healing. The lack of CD40L is related to increased collagen deposition,
while the lack of ADAMTS13 increases the extravasation of neutrophils in the early phase of wound
healing [38,39]. Platelet hyperactivity, impaired wound healing, and the accumulation of immune
cells along with high cytokine levels were observed upon the lack of TNFSF14 [40,41], and reduced
levels of CCL3 were observed in impaired wound healing [42]. THPO has a role in platelet synthesis,
but it was observed that treatment with the THPO receptor agonist slightly delayed the healing
rate in wounded mice [43]. Bikunin or inter-alpha trypsin inhibitor is related to impaired wound
healing; more pathological-appearing cells were observed after naphthalene injury in inter-alpha
trypsin inhibitor-deficient mice significantly [44]. There are no data regarding the CA5A, but it was
shown that the carbonic anhydrase is expressed in skin during wound healing, and its reduced levels
were observed in keloid scars [45]. At this point, we cannot properly address why the reduced
occurrence of leptin, NPPB, and FGF23 was observed in the samples originating from the group with
complications, but the reduced frequency of the other eight proteins already related to wound healing
can be explained; their reduced level was linked to wound-healing problems, as it is the case in the
group with complications. It also should be noted that data regarding the link between the examined
proteins and wound healing are mainly from studies on skin or airways, and conditions in the eye may
differ from those observed in other parts of the body. IL17C, IL10RA, IL20RA, FGF19, artemin (ARTN),
and TNFSF11 were found to appear more frequently in the samples of patients with complications
(Table 1). String analysis shows that these proteins do not interact with each other, and the only
enriched pathway was cytokine-binding (Figure 2b). It was already observed by different groups that
IL17C plays an important role in the innate immunity of the epithelium by stimulating the production
of antibacterial and immunomodulatory peptides through the NF-kappa-B and MAPK pathways [46],
and the overexpression of IL17C is associated with psoriasiform skin [47]. IL20 and its receptor IL20RA
promote the epithelial wound healing in mouse cornea [48], IL10RA promotes the survival of myeloid
cells [49], and TNFSF11, as a ligand for NF-kappa-B, promotes cell proliferation [50]. Artemin was
shown to enhance the migrating capability in wound healing, and many members of the FGF family
are applied as drugs helping the wound healing [51,52]. The increased frequency of proteins having
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roles in cell migration, cell proliferation, and enhancing wound healing in patients with complications
might give an explanation of the presence of complication being possibly related to the early closure of
the channel generated during trabeculectomy.
Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  9 of 20 
 
 1 
Figure 2. Proteins present with different frequency in the groups. (a) Proteins that are less likely to be 2 
present in samples belonging to a group with complications; (b) proteins that are more likely to be 3 
present in samples belonging to a group with complications. In both cases, the upper part of the figure 4 
shows the enrichment table generated by String. In the enrichment table, the name and GO code of 5 
the enriched pathway, the number of proteins belonging to the pathway, and the false discovery rate 6 
are indicated. The lower part of the figures show the network generated by String, with each ball 7 
representing a protein, and lines representing protein–protein interactions. Proteins colored with red 8 
participate in cytokine–cytokine receptor interaction, the blue color represents the proteins that are 9 
responsible for the regulation of immune system processes, and proteins colored with green 10 
participate in the regulation of the MAPK cascade, while the ones colored with yellow are responsible 11 
for receptor binding. Proteins are represented by their gene name. 12 
In order to have a more in-depth analysis, the qualitative examination was followed by 13 
quantitative analysis. The 184 proteins were examined, and 46 of the proteins could be detected in 14 
less than 30% of the samples (Table S2), so these proteins were excluded from further statistical 15 
analyses. The changes in the relative amount of the proteins were visualized on a heat map (Figure 16 
3a). Hierarchical clustering of the data revealed that, based on these protein signatures, the group 17 
with complications cannot be unanimously differentiated from the group without complications. 18 
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enrichment of proteins belonging to immune response GO (GO:0006955) function. Caspase 8 has a 21 
role in apoptosis, protein S100A12, TNF superfamily member 14, monocyte chemotactic protein 3 22 
(MCP-3/CCL7), chemokine (C-C motif) ligand 23 (CCL23), and NF-kappa-B essential modulator 23 
(NEMO/IKKBG) have pro-inflammatory functions, while the carcinoembryonic antigen-related cell 24 
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Figure 2. Proteins present with diffe nt frequency in the groups. (a) Proteins that are less likely to
be present in samples belonging to a group with complications; (b) proteins that ar m re likely to
be present in samples belonging to a group w th c mplications. In both cases, the upper part of the
figure shows the enrichment tabl generated by String. In th enrichment t bl , the name and GO code
of the enriched pathway, the number of proteins belonging to the pathway, an the false discovery
rate are indicated. The lower part of the figures show the network generated by String, with each ball
representing a protein, and lines representing protein–protein interactions. Proteins colored with red
participate in cytokine–cytokine receptor interaction, the blue color represents the proteins that are
responsible for the regulation of immune system processes, and proteins colored with green participate
in the regulation of the MAPK cascade, while the ones colored with yellow are responsible for receptor
binding. Proteins are represented by their gene name.
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Table 1. List of proteins with altered abundance in the group with complications. The percent of samples expressing the indicated protein in the group with and
without complications is listed in the case of each protein where the difference was more than 20% between the two groups. The direction of change in the group with
complication is indicated along with biological function and the role in wound healing in the case of each protein. * indicates the enriched Gene Ontology (GO)
function calculated by String, and # indicates function as listed in String. ADAMST13: A disintegrin and metallopeptidase with thrombospondin type 1 motif 13,
AMBP: alpha-1-microglobulin/bikunin precursor, CD40L: CD40 ligand, DECR1: 2,4-dienoyl CoA reductase 1, FCGR2B: IgG Fc fragment low affinity receptor, GIF:
gastric intrinsic factor, LEP: leptin, MARCO: macrophage receptor with collagenous structure, NPPB: atrial natriuretic factor, REN: renin, THPO: thrombopoietin,
TNSF14: tumor necrosis factor superfamily member 14.
Protein Code
According to
String
Protein Code
According to
Olink
% of Samples in
Group with No
Complications
% of Samples
in Group with
Complications
Change of
Protein
Abundance
Biological Function Role in Wound Healing
CD40LG CD40-L 74 45 decrease cytokine–cytokine receptor interaction, receptorbinding *
lack of CD40L leads to excessive collagen
deposition
ADAMTS13 ADAM-TS13 68 45 decrease receptor binding * lack of ADAMTS13 increases theextravasation of neutrophils
GIF GIF 68 45 decrease cyanocobalamin absorption # not identified yet
FGF23 FGF-23 89 55 decrease regulation of immune system process,regulation of MAPK cascade *
not FGF23 but other FGFs facilitate wound
healing
CD84 CD84 74 27 decrease
modulation of the activation and differentiation
of immune cells, regulation and interconnection
of innate and adaptive immune response #
not identified yet
REN REN 84 55 decrease regulation of MAPK cascade, receptor binding * depending on the conditions activates orinhibits wound healing
DECR1 DECR1 95 73 decrease Metabolism # not identified yet
AMBP AMBP 84 64 decrease regulation of immune system process,regulation of MAPK cascade *
AMBP deficiency is related to significantly
more pathological-appearing cells in
airway injury
FCGR2B IgG Fcreceptor II-b 47 18 decrease regulation of immune system process * not identified yet
THPO THPO 42 0 decrease regulation of immune system process,regulation of MAPK cascade, receptor binding *
THPO receptor agonist causes slight delay
in wound healing
MARCO MARCO 42 9 decrease regulation of immune system process * not identified yet
UGGT1 GT 26 0 decrease protein folding quality control # not identified yet
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Protein Code
According to
String
Protein Code
According to
Olink
% of Samples in
Group with No
Complications
% of Samples
in Group with
Complications
Change of
Protein
Abundance
Biological Function Role in Wound Healing
NPPB BNP 47 18 decrease receptor binding * promotes wound healing
LEP LEP 79 36 decrease
regulation of immune system process,
regulation of MAPK cascade, cytokine–cytokine
receptor interaction *
promotes wound healing
CA5A CA5A 32 0 decrease Metabolism # lower levels of carbonic anhydrase weredetected in keloid scars
TNFSF14 TNFSF14 100 73 decrease
regulation of immune system process,
cytokine–cytokine receptor interaction,
receptor binding *
lack of TNFSF14 helps the accumulation of
immune cells, increases cytokine levels,
impairs wound healing
CCL3 CCL3 89 64 decrease
regulation of immune system process,
regulation of mitogen-activated protein kinase
cascade, cytokine–cytokine receptor interaction,
receptor binding *
helps macrophage recruitment; decreased
CCL3 levels were observed in impaired
wound healing
IL17C IL-17C 37 64 increase cytokine–cytokine receptor interaction # overexpression is observed in psoriasis
IL20RA IL-20RA 53 82 increase cytokine–cytokine receptor interaction * promotes corneal epithelial healing
IL10RA IL-10RA 5 36 increase cytokine–cytokine receptor interaction * promotes survival of myeloid cells
TNFSF11 TRANCE 16 36 increase cytokine–cytokine receptor interaction*,cell proliferation # not identified yet
ARTN ARTN 47 91 increase neurotrophic factor, ligand for theRET receptor # facilitates wound healing
FGF19 FGF-19 37 64 increase regulation of bile acid synthesis # not FGF19 but other FGFs facilitate woundhealing
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In order to have a more in-depth analysis, the qualitative examination was followed by
quantitative analysis. The 184 proteins were examined, and 46 of the proteins could be detected
in less than 30% of the samples (Table S2), so these proteins were excluded from further statistical
analyses. The changes in the relative amount of the proteins were visualized on a heat map (Figure 3a).
Hierarchical clustering of the data revealed that, based on these protein signatures, the group
with complications cannot be unanimously differentiated from the group without complications.
However, higher protein amounts could be observed in case of 14 proteins in the samples belonging
to the group with complications (Figure 3b). Functional analysis of these proteins shows an
enrichment of proteins belonging to immune response GO (GO:0006955) function. Caspase 8 has a
role in apoptosis, protein S100A12, TNF superfamily member 14, monocyte chemotactic protein 3
(MCP-3/CCL7), chemokine (C-C motif) ligand 23 (CCL23), and NF-kappa-B essential modulator
(NEMO/IKKBG) have pro-inflammatory functions, while the carcinoembryonic antigen-related cell
adhesion molecule 8 (CEACAM8) and spondin 2 have a role in cell adhesion. The osteoclast-associated
immunoglobulin-like receptor (OSCAR) participates in osteoclast differentiation, but also functions
in neutrophil degranulation, and can activate TNF-α release from inflammatory monocytes [53].
Superoxide dismutase (SOD2) and glyoxalase 1 (GLO1) may have protective roles preventing the
accumulation of free radicals and advanced glycation end products (AGEs), and their reduced activity
or expression was found to be associated with delayed wound healing [54–57]. In a corneal wound
healing model, the expression of poly-ADP ribose polymerase-1 (PARP-1) was shown to be upregulated
by fibronectin, while PARP-1 activation in skin was associated with delayed wound healing [58,59].
The increased amount of PARP-1, osteoclast-associated immunoglobulin-like receptor, SOD2, and
GLO1 may indicate the presence of additional stress factors in the group where complications are
present. The signal transducing adapter molecule (STAM)-binding protein initiates cell growth and
cell proliferation, while the eukaryotic initiation factor EIF4EBP1 has a role in the regulation of
translation; both are needed for the increased cell proliferation that is required for wound closure [60].
The increased amounts of molecules whose decrease was associated with the delayed wound healing
(SOD2, GLO1, PARP-1) and of those molecules that have a role in proliferation (STAM-binding protein,
EIF4EBP1) might reflect premature wound healing, leading to the ineffective trabeculectomy that is
characteristic in the group with complications.
Proteins are represented by their abbreviations as follows: 4E-BP1 = EIF4EBP1: eukaryotic
translation initiation factor 4E binding protein 1, CASP8: caspase 8, CCL3: chemokine (C-C motif)
ligand 3, CCL23: chemokine (C-C motif) ligand 23, CEACAM8: carcinoembryonic antigen-related cell
adhesion molecule 8, EN-RAGE = S100A12: S100 calcium binding protein A12, IL8: interleukin 8, IL18:
interleukin 18, GLO1: glyoxalase 1, MCP-1 = CCL2: chemokine (C-C motif) ligand 2, MCP-3 = CCL7:
chemokine (C-C motif) ligand 7, MMP12: macrophage metalloelastase, NEMO = IKBKG- NF-kappa-B
essential modulator, OSCAR: osteoclast associated, immunoglobulin-like receptor, PARP1: poly
(ADP-ribose) polymerase 1, PIGR: polymeric immunoglobulin receptor, PRELP: proline/arginine-rich
end leucine-rich repeat protein, SOD2: superoxide dismutase 2, SPON2: spondin 2, STAMBP: STAM
binding protein, TNFSF14: tumor necrosis factor (ligand) superfamily, member 14, TNFRSF10A:
tumor necrosis factor receptor superfamily, member 10a, TNSFRSF11A: tumor necrosis factor
receptor superfamily, member 11a. Note that the presence of different abbreviations for the same
protein on panel b and c (4E-BP1—EIF4EBP1, EN-RAGE—S100A12, NEMO—IKBKG, MCP-3—CCL7,
MCP-1—CCL2) are due to the utilization of different protein databases by the different software tools.
According to a non-parametric Mann–Whitney U-test, nine proteins showed statistically
significant differences between the two groups (Table S4). All of the proteins except for the polymeric
immunoglobulin receptor (PIGR) showed an increase in the amount in samples belonging to the group
with complications. The network analysis revealed a network with few connections, and the enriched
pathways were related to immune response (Figure 3c). MMP12 could not be visualized in the network,
because the String database did not contain this protein at the time of analysis. IL8, IL18, MCP-1,
CCL3, and the TNF receptor superfamily members 10A and 11A participate in cytokine–cytokine
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receptor interaction, while PIGR has a role in IgA and IgM binding, and the proline/arginine-rich and
leucine-rich repeat protein has a role in extracellular matrix assembly [61]. MMP12 was found to be
responsible for ocular wound healing, promoting the early repair process of the corneal epithelium
by enhancing epithelial cell migration and neutrophil infiltration [62]. As it was expected, the results
of both the qualitative and quantitative analyses show that proteins that have a role in the immune
response and wound healing were changed in case of patients with complications. In order to get
more information on the events regulating the wound healing and be able to monitor the effect of the
time and/or complication on the relative protein levels, a rigorous in-depth statistical analysis using a
linear mixed model was performed.
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Figure 3. Cluster analysis and heat map of proteins analyzed in tears of patients with glaucoma who
underwent trabeculectomy. (a) Relative protein amount (NPX) in case of proteins with higher than
30% detectability characteristic for each sample; (b) a magnified image of the heat map for proteins
showing a higher expression level in the samples belonging to the group with complications is shown,
along with the network and the enriched GO terms and pathways. In the enrichment table, the name
and GO code of the enriched pathway, the number of proteins belonging to the pathway, and the false
discovery rate are indicated. In the network, each ball represents a protein. Proteins colored with yellow
participate in monocyte chemotaxis, while those colored with red have a role in the immune response,
proteins with the blue color participate in the regulation of NF-kappa B signaling, and those colored
with green have a role in leukocyte migration; (c) a magnified image of the heat map for proteins
showing significantly altered expression levels in samples belonging to group with complications is
shown, along with the network and the enriched GO terms and pathways. In the enrichment table, the
name and GO code of the enriched pathway, the number of proteins belonging to the pathway, and
the false discovery rate are indicated. Proteins colored with green participate in cytokine–cytokine
receptor interaction.
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Regarding the effect of time, the level of IL6 and MMP-1 changed in a statistically significant way,
according to our data. The level of both IL6 and MMP-1 increased in a statistically significant manner
on postoperative day one, remained high on days two and four, and went back to the original level
three months after the surgical intervention (Figure 4). The changes between day zero and day one,
day two, and day four, respectively, were statistically significant, as were the changes between day
one, day two, and day four, respectively, and at three months (day 90) as well. The changes between
the group with complications and group without complications were not statistically significant.
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Figure 4. NPX values over the time in the case of proteins with statistically significant differences.
The “x” axis shows the time points, and the “y” axis shows the mean NPX values in the cases of patients
with complications (blue color) and without complications (red color) following trabeculectomy. All of
the time points were compared to each other; arrows and * indicates statistical significance p < 0.05.
IL6 was present in both panels; in this way, it was measured twice, and the very similar behavior of
this protein in the two assays provides further evidence for the good replicability of the assays. IL6 has
a role in the inflammatory part of wound healing, and is released right after ocular injury [8]. It is
known that upregulating the integrin-type fibronectin receptor IL-6 facilitates epithelial cell migration,
stimulates the attachment of corneal epithelial cells to collagen type IV and laminin matrices, and may
influence the production of fibrotic material by activated keratocytes [63]. The increased level of IL6
observed in tears at postoperative days one, two, and four most probably reflects the higher levels
of this cytokine, which is characteristic for the migration and proliferation phases of ocular wound
healing (Figure 5). At the same time, the higher level of IL6 that was observed in the tears of patients
with complications at all of he postoperative time points s pp rts our previous observation that an
increase in the rela ive amount of proteins participating in immune reac is detectable in samples
originating from patients with complications.
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Following injury in the first few hours in the lag or latency phase, the released cytokines (mainly
IL-1, IL-6, TNF-α, and IL-8) orchestrate the early events of epithelial wound healing. The damaged cells
are dying mainly by apoptosis, and the recruited immune cells help the debridement and the clearance
of apoptotic cells. MMPs are activated by IL-1 and other factors, and an extensive extracellular matrix
rearrangement starts. The epidermal (EGF), hepatocyte (HGF), keratocyte (KGF), platelet-derived
(PDGF), and nerve (NGF) growth factors that are released upon injury or by the action of cytokines
help the wound-healing process. During this phase, some of the existing cellular junctions are removed;
there is a fibronectin polymerization to help the cell migration, and focal contacts are formed at the
wound margin, preparing the conditions for cell migration. In the migration phase, cells migrate
to the site of the wound to cover the wound bed. The migration starts approximately five hours
after the injury, and is directed by IL-6, KGF, HGF, and PDGF, which is followed by cell proliferation
stimulated by the strong mitogenic effect of growth factors. At the same time, extensive synthetic
processes are taking place, and the formation of the basement membrane and restoration of the barrier
functions happen.
In the stroma, injury is followed by the keratocyte apoptosis and recruitment of the immune
cells. IL-1 and TGFβ released in the epithelial cell layer diffuse to the stroma due to the defects of the
basement membrane, and regulate the early events of stromal wound healing. The immune cells and
keratocytes transform to fibroblasts and myofibroblasts mainly upon the action of TGFβ, and migrate
to the site of the injury to fill up the wound. Meanwhile, the keratocytes and fibroblasts secrete growth
factors that help the cell proliferation both in the stroma and the epithelial cell layer. The stromal and
the epithelial wound healing ends with a slow and long remodeling phase. During this phase in the
epithelial cell layer, the stratification of the cells happens, and the firm adherence of the cells to the
underlying structures is reestablished. In the stroma, there is an extensive collagen remodeling, and
the myofibroblasts disappear. Regarding the endothelial injury, cell migration is the most important
process; the endothelial cells migrate to the site of injury, fill up the gap, and secrete a new basement
membrane to restore the barrier functions, if necessary.
MMPs have a role in extensive extracellular matrix (ECM) remodeling, which is required for
proper wound healing. They have a prominent role in the migration phase, helping cell migration, the
recruitment of immune cells, and the production of new fibrotic material (Figure 5). We could observe
the increase of MMP-1 in the early postoperative time points, when the matrix metalloproteinase
activity promotes the rearrangement of the extracellular matrix, the disintegration of the cell–ECM
junctions, the initiation of cell migration, and a decline in the MMP-1 amount at a later time point.
According to our data, both IL6 and MMP-1 have a role not only in the latency and migration
phases of ocular wound healing, but also in the proliferation phase and possibly at the early events of
the attachment and slow remodeling phases (Figure 5).
Pathway analysis showed that the relevant pathway involving both IL6 and MMP-1 was the
“photodynamic therapy-induced” pathway (Figure 6). According to this pathway, NF-kappa B
signaling is activated, which in turn activates among the others the expression of interleukins such
as IL6 and of matrix metalloproteinases such as MMP-1. When this pathway is activated in tumor
cells, it leads to an inflammation followed by leukocyte migration into the tumor tissue, leading to the
apoptosis of the tumor cells [64]. During ocular wound healing, the damaged cells die by apoptosis
and necrosis, and the immune cells are recruited to help the tissue regeneration and the clearance of
dead cells [8]. The higher activity of this pathway in the first few days (days one, two, and four) after
surgery might be responsible for the inflammatory part of the wound-healing process.
Data of the qualitative and quantitative analyses are in line with each other and in accordance
with the literature data that indicate a different wound-healing balance in the two groups. In the group
with complications, the lower frequency of proteins having a role in the regulation of wound healing
and of CA, whose low levels were found in keloid scar formation, was observed. At the same time,
higher levels of proteins having a role in immune response, cell proliferation, ECM rearrangements,
wound healing, and proteins whose low levels were associated with delayed wound healing (ex. SOD2,
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GLO1), indicate a more pronounced wound healing compared to the group without complications.
Although our data show that the presence and the amount of proteins that have roles in the immune
reaction and wound healing are altered in the case of patients with complications, these data have
to be considered carefully, since the number of patients recruited into the study was relatively low.
New studies with larger number of patients are needed to confirm the increased level of these proteins
as possibly responsible for the appearance of complications. Considering that the inflammation is
relatively manageable from a therapeutic point of view, these data, if validated on a larger sample size,
might help improve the later outcomes of trabeculectomy.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  15 of 20 
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Figure 6. Photodynamic therapy-induced pathway. The proteins highlighted with blue are the proteins
that are present in the analyzed panels, while the proteins marked with green indicate those that
show statistically significant changes. Green arrows indicate activation, while red arrows indicate
inhibition. The pathway was drawn based on Wikipathway WP3617 (www.wikipathways.org/index.
php/Pathway:WP3617).
3. Materials and Methods
3.1. Subjects and Tear Sample Collection
The sample collection was done in accordance with the Declaration f Helsinki, and was approved
by the Ethical Committee of he University of Debrecen (approval number: 4234-2014, 11/11/2014).
Recruited subjects (six females two males) ere patients of the Departm nt of Ophthalmology,
Faculty of Medicine, University of D brecen, and gave written informed consent for sample collection.
All of the patients underwent trabeculectomy surgery to reduc intraocular pressure at the Departmen
of Ophthalmology, Faculty of Medicine, University of Debrecen. A follow-up study includi g eight
patients was carried ou , and tear samples w re collected before trabecul ctomy (day 0), at day one,
day four, and three months after the surgery. One of the pati nts did not prese t on the three-month
control; as a r sult, t sample could be collected only at the 10-month time point after the surgery.
Exclusion criteria w re the presence of autoimmune disease and/or any ocular surface disease other
than glaucoma. The non-inva ive tear collect on was carried out before the trabeculectomy using sterile
glass capillary tubes (VWR Ltd., Radnor, PA, USA) for two minutes from the lateral inferior meniscus
without local anesthesia or stimulation [65]. Tear samples were centrifuged at 4 ◦C at 2.4× g for 10 min
in a benchtop Eppendorf centrifuge; then, the supernatants were aliquoted to five-µL aliquots and
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deep frozen and stored at −70 ◦C until analysis. Protein concentration of tear samples was determined
using the Bradford method [66]. At the time of tear collection, an ophthalmological examination was
also carried out.
3.2. Relative Quantification of 186 Proteins in Tear by Proximity Extension Assay
Proteins of interest were selected based on previous experiments, and the scientific literature was
analyzed by the analysis service of Olink Proteomics (Uppsala, Sweden). Four µL of tears in the case
of each sample was shipped on dry ice to Olink Proteomics, and one µL of undiluted and 4x diluted
tears, respectively, was used for the analyses. The relative protein quantification was performed using
PEA-based panels. The proteins of interest could be found in the inflammation panel and CVD panel II,
so these two panels were analyzed. Each panel was able to simultaneously analyze 92 selected proteins,
as listed in Supplementary Table S1. Using proper internal and external controls, the raw values
were normalized for variation between and within runs, and were converted into normalized protein
expression units (NPX), which are arbitrary units on log2 scale, allowing for the relative quantification
of proteins this way.
3.3. Functional Analysis
The hierarchical clustering of proteins detected in more than 30% of the samples was performed
using Gene Cluster 3.0 (http://cluster2.software.informer.com/), and the heat map was created with
Java TreeView version 1.1.6r4 [67]. Before clustering, no filtering or adjustment of the data was
performed, the distance/similarity measures were based on the Pearson correlation, and the clustering
was done by complete linkage analysis. The network of selected proteins was drawn with String
10.5 [30,31] using default settings and medium stringency, and the proteins belonging to the enriched
GO functions were highlighted.
Pathway analysis was performed on proteins with statistically significant changes using
the Wikipathways (https://www.wikipathways.org/index.php/WikiPathways) search function.
The pathways were manually evaluated for their relevance.
3.4. Statistical Analysis
A non-parametric Mann–Whitney U-test was applied to compare the mean NPX values that
were characteristic for the two groups. The statistical analysis was performed using SPSS 25.0
(IBM Inc., Armonk, NY, USA). For the examination of the effect of surgery and/or time on the
relative protein amounts, a linear mixed model and ANOVA was applied using ImerTest function in
R [68]. Sixty samples from eight different patients at four different time points were included in the
analyses. Samples that did not pass quality control (QC) as defined by Olink were included in the
analysis, since their distribution did not appear to differ from the other samples. Proteins with lower
than 30% detectability were removed from the analysis, resulting in 138 out of 184 proteins.
Time point and complications were included as fixed effects, and were considered variables of
interest. The subject ID was included as a random effect, estimating and controlling for the base protein
expression level in each subject. Due to the low number of patients recruited, the effect of gender was
not examined. p-Values for the fixed effect were estimated using Satterthwaite’s approximation
of degrees of freedom, and were corrected for multiple testing using the Benjamini–Hochberg
approach [69]. For each significant assay, a post hoc test was performed to estimate the population
mean and pairwise differences between groups. Post hoc p-values were calculated using the Tukey
method [70].
4. Conclusions
We could observe that proteins having a role in immune response and wound healing
appear with altered frequency and/or amounts in the samples originating from patients with
complications following glaucoma surgery compared to samples from patients with no complications.
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Further verification and the extension of the study with a higher number of recruited patients are
required in order to validate our data and possibly identify new diagnostic and therapeutic target
proteins. Based on our data, PEA is a method that is suitable for the analysis of tear samples, and
can be a method of choice in the examination of basal tear permitting the relative quantification of
hundreds of proteins in individual tear samples.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/12/
4096/s1.
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